Loading company
$281.14+1.1%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed November 5, 2026
Past performance
- 1W
- +3.5%
- 1M
- +10.8%
- 3M
- +19.8%
- 6M
- +44.7%
- 1Y
- +38.2%
- 5Y
- +524%
Trailing twelve months where a flow is involved, latest reported balance where it is not.
Pharmaceutical and Specialty Solutions is 92% of revenue.
Year to Jun 30, 2025 · $222.7B
Year to Jun 30, 2025 · $222.7B
Both on one scale, because both are money — the bar that is taller is the one that matters.
Cash counts short-term investments, not just the bank balance — technology companies park most of it in marketable securities, and leaving those out understates it several times over. Debt includes lease obligations.
Only the three costs filers report consistently. Anything a company does not break out sits outside these bands, so the stack is not the whole cost base.
Not on the overview because five charts is as much as one decision needs — but here in full, on one period switch. Each bar sums the four quarters ending there — a full year, brought up to today.
$254.25BQ2 2026
Everything the company sold, before any costs. Each bar sums the four quarters ending there — a full year, brought up to today.
$3.42BQ4 2025+6.2%
Operating profit before depreciation and amortisation — approximated from operating income, because no depreciation tag is reported consistently enough across filers to do better. Treat it as indicative. Each bar sums the four quarters ending there — a full year, brought up to today.
$1.71BQ2 20260.7% of revenue
What was left after every cost, including tax. Each bar sums the four quarters ending there — a full year, brought up to today.
0.7%Q2 2026
How much of every dollar of sales the company keeps as profit. A grocer keeps a few cents; a software company can keep half. Each point covers the four quarters ending there — a full year, brought up to today.
$5.5BQ4 2025+23.6%
Cash left over after running and maintaining the business. Each bar sums the four quarters ending there — a full year, brought up to today.
$7.232026+12.1%
The same profit, split across every share. If this lags the profit chart above, the company is issuing shares and your slice is getting smaller. Restated onto today’s share count, so stock splits do not show as jumps. One bar per fiscal year, as filed. Stops at the last completed year.
237MQ2 2026
How many shares the profit is divided across. Rising is dilution; falling is the company buying itself back. Restated onto today’s basis, so splits do not show as jumps. Each point covers the four quarters ending there — a full year, brought up to today.
36.7x2026-21.7%
36.7x today · median 36.7x and range 9.9x–80.5x across the points shown, 2017 to 2026 The breaks in the line cover 2 periods with no meaningful multiple — a loss, or earnings so small the ratio says more about the denominator than the price.
Paid per unit of yearly profit. Periods with a loss, or profits too small for the ratio to mean anything, are left out — the line breaks rather than drawing through them. Each point covers the four quarters ending there — a full year, brought up to today.
$491MQ2 2026
Cash handed to shareholders. A flat line at zero means the company pays none. Each bar sums the four quarters ending there — a full year, brought up to today.
Everything above comes from Cardinal Health, Inc.’s own filings with the SEC, as reported. No estimates, no analyst figures, nothing adjusted.
Not reported by this filer: R&D Expense, Total Operating Expenses, Interest Income, Net Interest Income, Non-interest Income, Non-interest Expense, Deposits, Total Liabilities, Borrowings (total), Change in Receivables, Change in Payables and Accruals, Change in Customer Advances, and Change in Working Capital. Companies choose which XBRL tags to use, and anything untagged cannot be recovered — so these are blank rather than guessed.
$281.14+1.1%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed November 5, 2026